CHAPTER 5 Nervous System^223
- Occipital lobe:
- Impaired vision—defect in visual fields; patient may deny or be unaware
of defect - Prosopagnosia (patient is unable to recognize familiar faces)
- Change in color perception
- Impaired vision—defect in visual fields; patient may deny or be unaware
- Parietal lobe:
- Seizures
- Sight disturbances result in visual field defect
- Sensory loss—unable to identify object placed in hand without looking
- Temporal lobe:
- Seizures
- Taste or smell hallucinations
- Auditory hallucinations
- Depersonalization
- Emotional changes
- Visual field defects
- Receptive aphasia
- Altered perception of music
INTERPRETING TEST RESULTS
- MRI with gadolinium (contrast) defines tumor location, size.
- CT scan shows characteristic appearance of meningioma.
- Angiography will show blood flow to the area; some tumors will displace
vessels as they grow.
TREATMENT
- Chemotherapeutic agents alone or in combination with radiation and surgery.
May be given orally, intravenously or through an Ommaya reservoir. Drugs
are chosen based on cell type:- carmustine, lomustine, procarbazine, vincristine, temozolomide, erlotinib,
gefitinib
- carmustine, lomustine, procarbazine, vincristine, temozolomide, erlotinib,